Start:
December 30, 2020
End:
March 2024
Enrollment:
70
Transcranial alternating current stimulation (tACS) is a noninvasive method of applying weak electrical current to the brain using a cap with electrodes worn on the head. This study will test the effects of tACS to improve cognition in people with behavioral variant frontotemporal dementia (bvFTD). Participants will be randomly assigned to receive either the tACS intervention or a sham stimulation, daily for six weeks. In addition, participants will undergo assessments and tests, including a position emission tomography brain scans, so researchers can measure the effects of the stimulation on cognition, brain electrical activity and energy use, and brain plasticity, which is the brain's ability to create new neural connections. The study will also enroll 20 healthy volunteers who will receive the same assessments as the bvFTD participants, but will not receive the tACS intervention.
Minimum Age: 40 Years
Maximum Age: 80 Years
All Participants:
Participants With bvFTD:
Healthy Volunteers:
All Participants:
Participants With bvFTD:
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Massachusetts | |
---|---|
Beth Israel Deaconess Medical Center
Boston,
MA
02215
Recruiting
Julianne Reilly |
Lead: Beth Israel Deaconess Medical Center
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT04425148
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health